Analyst consensus rating
PAVmed Analyst Rating: Strong Buy
PAVM is rated Strong Buy by 2 analysts with a $36.50 target. As of 2026-08-31.
Direct answer
PAVmed's consensus rating is Strong Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $36.50.
Forecast evidence checked August 31, 2026.
Get free PAVmed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.92
- Average price target
- $36.50
- High price target
- $57.00
- Low price target
- $16.00
- Low target gap
- +225.2%
- Target upside
- +641.9%
- High target gap
- +1,058.5%
- Target range width
- 833.3%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for PAVmed?
PAVmed has a verified Strong Buy consensus. The same dataset has an average price target of $36.50.
How far are PAVmed's low and high targets from the recorded price?
The low target implies +225.2%, while the high target implies +1,058.5%.
How many analysts are included in PAVmed's consensus?
The verified consensus includes 2 analysts.
How is PAVmed's target upside or downside calculated?
The average target of $36.50 is divided by the recorded price of $4.92, then one is subtracted to produce +641.9%. This does not guarantee a future return.
When was PAVmed's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.